Medallion Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Medallion Wealth Advisors's PFE Position: Q3 2026 in Review
Medallion Wealth Advisors reduced its Pfizer (PFE) stake by 4.8% in Q3 2026, selling an estimated $19.6K and leaving 14,606 shares worth $417K. The position accounts for 0.13% of the portfolio, ranked #147.
Medallion Wealth Advisors first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $500K in Q1 2026. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Medallion Wealth Advisors held 14,606 shares of Pfizer worth $417K as of Q3 2026.
- Medallion Wealth Advisors sold 737 Pfizer shares in Q3 2026, an estimated $19.6K.
- Pfizer made up 0.13% of Medallion Wealth Advisors's portfolio in Q3 2026, its #147 holding.
- Medallion Wealth Advisors first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- Medallion Wealth Advisors's Pfizer position peaked at $500K in Q1 2026.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.